妥泰加用治疗成人难治性部分性癫痫的疗效观察

被引:15
作者
赵翕平
石静萍
陈惠玲
李作汉
管青山
机构
[1] 南京医科大学附属脑科医院神经科
关键词
妥泰; 加用治疗; 难治性部分性癫痫;
D O I
暂无
中图分类号
R742.1 [癫痫];
学科分类号
1002 ;
摘要
目的 观察妥泰 (TPM)加用治疗成人难治性部分性伴或不伴继发全身性发作 (GTCS)的疗效、安全性及耐受性。方法  5 6例在不动原用抗癫痫药 (AEDs)的基础上加用 TPM治疗 2 0周 ,前 8周为加量期 ,后 12周为维持治疗的稳定期。治疗前 (基础期 )记录好发作频率、用药情况、体重等作为自身对照。TPM自 2 5m g/ d开始 ,逐渐加量 ,目标剂量为 2 0 0 m g/ d。治疗前及治疗结束各查基础 AEDs血药浓度进行比较。治疗结束行全面疗效分析。结果  TPM加用治疗 2 0周后 ,与基础期发作频率比较 ,6 4.2 9%患者发作频率降低≥5 0 % ;2 5 .0 0 %患者发作频率降低≥ 75 % <10 0 % ;16 .0 7%完全不发。不良反应轻至中度 ,但与合用 AEDs的多少有关。 5 0 %患者体重可有不同程度的下降。TPM对卡马西平及丙戊酸钠血药浓度影响不大。结论  TPM是治疗难治性部分性伴或不伴继发 GTCS的安全有效的药物。
引用
收藏
页码:84 / 87
页数:4
相关论文
共 9 条
[1]  
Easterling DE,Zakszewski T,Moter MD,et al.Plasma pharmacokinetics of topiramate, a new anticonvulsant in humans. Epilepsia . 1988
[2]  
Rosenfeld WE,Liao S,Kramer LD,et al.Comparison of the steady-state pharmacokinetics of topiramate and valproate in patients with epilepsy during monotherapy and concommitant therapy. Epilepsia . 1997
[3]  
Brodie MJ,Biton V,Montouis GD,et al.Topiramate therapy in patients with generalized tonic-clonic seizures with or without focal onset : Long-term outcome. Epilepsia . 1998
[4]  
Ritter FJ,Glauser TA,Sachdeno RC,et al.Long-term experince with topiramate in Lennox-Gastaut syndrome. Epilepsia . 1998
[5]  
Glauser TA,Elterman R,Wyllic E,et al.Open-label topiramate in pediatric partial epilepsy. Epilepsia . 1997
[6]  
Sachdeo RC,Sachdeo SK,Walker SA,et al.Steadystate pharmacokinetics of topiramate and carbamazepine in papients with epilepsy during monotherapy and concommitant therapy. Epilepsia . 1996
[7]  
Shorvon SD.Safety of topiramate: adverse events and relationships to dosing. Epilepsia . 1996
[8]  
Reife RA,Lim P,Pledger G.Topiramate: side-effect profile in double-blind studies. Epilepsia . 1995
[9]  
Faught E,Wilder BJ,Ramsay RE,et al.Topiramate placebocontrolled dose-renging trial in refractory partial epilepsy using 200 -, 400 -, and 1000 - mg daily dosage. Neurology . 1996